Sep 18, 2019 / 11:10AM GMT
Unidentified Analyst -
Hey, everybody. Thanks. It's my pleasure to be able to introduce our next company. I'm putting my U.S. biotech hat back on again as I did this morning while we're between biotech analysts. So our next company is Incyte. I'm very pleased to be able to introduce Hervé Hoppenot, who's the Chairman and President and CEO. I also remember Hervé from the time he's at Novartis as well, so it's like welcoming back old friends.
So Hervé has a presentation, and then we'll be able to move over to some interesting Q&A afterwards. So Hervé, I should like to give the floor to you.
HervéHoppenot - Incyte Corporation - Chairman, President & CEO
Okay. Well, thank you. Thank you for inviting us. So what I was thinking could be useful in a few minutes is basically to describe a little bit all the components of Incyte here because it's a very complete picture of many different projects going on different time lines. So let's see if we can go through the forward-looking statements and a brief description of the franchise, really,
Incyte Corp at Bank of America Merrill Lynch Global Healthcare Conference Transcript
Sep 18, 2019
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers